Clinical outcomes of post‐renal transplant patients with COVID‐19 infection in the ICU: A single‐center case series |
| |
| Authors: | Nissar Shaikh Mohamad Y. Khatib Mohammad A. Alwraidat Dore C. Ananthegowda Muftah Othman Asra Aroos Sagar B. Jujjavarapu Saptarshi Banerjee Zishan Nasir Ahmed S. Mohamed Moustafa S. Elshafei Muna A. Almaslamani Abdulqadir J. Nashwan |
| |
| Affiliation: | 1. Surgical Intensive Care Department, Hamad General Hospital (HGH), Hamad Medical Corporation (HMC), Doha Qatar ; 2. Medical Intensive Care Department, Hazm Mebaireek General Hospital (HMGH), Hamad Medical Corporation (HMC), Doha Qatar ; 3. Nephrology Department, Hazm Mebaireek General Hospital (HMGH), Hamad Medical Corporation (HMC), Doha Qatar ; 4. Communicable Diseases Center (CDC), Hamad Medical Corporation (HMC), Doha Qatar |
| |
| Abstract: | Most of the post‐renal transplant patients are taking immunosuppressive medications, including calcineurin inhibitors, anti‐proliferative agents, and steroids. This case series highlights the clinical characteristics and outcomes of eight post‐renal transplant patients with severe COVID‐19 infection admitted to the intensive care unit. |
| |
| Keywords: | acute kidney injury, COVID‐ 19 infection, end‐ stage renal disease, hypertension, immunosuppression, renal transplant |
|
|
